Compound Profile

Yohimbine

Yohimbine compound profile with evidence, safety, and practical fit.

Last reviewed: 1 human studies cited

A Strong

Monograph visual

Yohimbine

Generated profile category visual

Where to go next — guides & comparisons

Continue reading

Quick Stats

Evidence level

Strong evidence

Typical onset

Varies by prep

Safety rating

Use extra caution: Safety review pending

Best for

Alpha 2 Adrenergic Receptor

Avoid / review if

Monoamine Oxidase Inhibitor Medications Due To Hypertensive Crisis Risk, Hypertension Or Other Cardiovascular Disease Including Recent Heart Attack Or Arrhythmia, Severe Kidney Or Liver Disease Reduces Clearance

Safety & Cautions

Review before use if any apply: Monoamine Oxidase Inhibitor Medications Due To Hypertensive Crisis Risk, Hypertension Or Other Cardiovascular Disease Including Recent Heart Attack Or Arrhythmia, Severe Kidney Or Liver Disease Reduces Clearance.

Evidence-based safety

Caution when combined

These pairings share a flagged risk mechanism. They are additive-effect cautions derived from contraindication data, not confirmed clinical interactions. Consult a clinician before combining.

High-Priority Caution

26 flagged pairings

Serotonergic activity

Moderate Caution

81 flagged pairings

Blood-pressure effects

Evidence Summary

A Strong

Evidence lens

Most useful for practical interpretation when safety context also fits.

StrongStrong evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedMetabolic Regulation · Vascular Function Support · Adrenergic

Research maturity: More interpretablemain contexts: Alpha 2 Adrenergic Receptor

Safety boundary: Safety note availableReview before use if any apply: Monoamine Oxidase Inhibitor Medications Due To Hypertensive Crisis Risk, Hypertension Or Other Cardiovascular Disease Including Recent Heart Attack Or Arrhythmia, Severe Kidney Or Liver Di

This profile cites 1 human study.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Strong evidence

Yohimbine has a strong evidence evidence rating.

General wellnessGeneral wellness
Citation density
1.0
Sources
1
Effects
1
Research recency
Mixed recency
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

A

Strong

Multiple RCTs, consistent direction, adequate effect size

B

Moderate

Some RCTs or consistent observational data in humans

C

Preliminary / Mixed

Animal or in-vitro only, or conflicting human data

D

Traditional / Theoretical

Traditional use only; no controlled human trials

Clinical Study Summaries (1)Cited studies informing this profile. RCTs and reviews shown first.

How Yohimbine Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Yohimbine Works

How Yohimbine WorksYohimbine acts on pathways via metabolic (regulation), leading to alpha 2 adrenergic receptor.YohimbineBiological pathwayMetabolicRegulationAlpha 2 Adrenergic ReceptorObservable outcomeVascular FunctionSupport
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

Metabolic RegulationVascular Function SupportAdrenergicMetabolic

Condition guides

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Yohimbine

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Free safety checklist

Get the Yohimbine evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Compound profile context

How to interpret Yohimbine

Yohimbine dosage by use case, onset and duration, safety limits, and interactions for alpha 2 adrenergic receptor, graded against research. Strong Human… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing Yohimbine, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.